Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

117.05p
   
  • Change Today:
      0.55p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.81m
  • Volume: 7,311
  • Market Cap: £99.28m
  • RiskGrade: 196
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
73.07% above the market average73.07% above the market average73.07% above the market average73.07% above the market average73.07% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
11.83% above the market average11.83% above the market average11.83% above the market average11.83% above the market average11.83% above the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Book Ratio
51.22% below the market average51.22% below the market average51.22% below the market average51.22% below the market average51.22% below the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
76.9% below the market average76.9% below the market average76.9% below the market average76.9% below the market average76.9% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Price Chg 3m
21.19% below the market average21.19% below the market average21.19% below the market average21.19% below the market average21.19% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
64.65% below the market average64.65% below the market average64.65% below the market average64.65% below the market average64.65% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Momentum 20
78.94% below the market average78.94% below the market average78.94% below the market average78.94% below the market average78.94% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
52.16% below the market average52.16% below the market average52.16% below the market average52.16% below the market average52.16% below the market average
Sector averageSector averageSector averageSector averageSector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
68.01% below the market average68.01% below the market average68.01% below the market average68.01% below the market average68.01% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
11.8% below the market average11.8% below the market average11.8% below the market average11.8% below the market average11.8% below the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
Operating Profit Loss
60.36% below the market average60.36% below the market average60.36% below the market average60.36% below the market average60.36% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.20% above the market average3.20% above the market average3.20% above the market average3.20% above the market average3.20% above the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
Cash
14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average
43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
18.72% above the market average18.72% above the market average18.72% above the market average18.72% above the market average18.72% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Buys 1y
69.81% below the market average69.81% below the market average69.81% below the market average69.81% below the market average69.81% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 117.05p
Change Today 0.55p
% Change 0.47 %
52 Week High 150.00
52 Week Low 108.00
Volume 7,311
Shares Issued 84.81m
Market Cap £99.28m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Price Trend
16.1% below the market average16.1% below the market average16.1% below the market average16.1% below the market average16.1% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
Income Not Available
Growth
44.37% above the market average44.37% above the market average44.37% above the market average44.37% above the market average44.37% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average

Diaceutics Dividends

No dividends found

Trades for 08-Jul-2025

Time Volume / Share Price
11:18 4,701 @ 116.75p
10:49 1,000 @ 116.75p
08:00 1,610 @ 120.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page